MedPath

Impact of new approaches to pharmacological management of patients with renal cell carcinoma: a population-based study of process and outcomes in The Netherlands

Phase 4
Recruiting
Conditions
kidney cancer
renal cell cancer
10038364
Registration Number
NL-OMON35060
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
1000
Inclusion Criteria

Adult patients with newly diagnosed kidney cancer

Exclusion Criteria

Age => 18

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath